IDEAYA Biosciences (IDYA) Reports Q4 Loss of $0.18/sh
IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.18), versus ($0.53) reported last year. Revenue for the quarter came in at $10.57 million, versus $0 reported last year.
For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.
